Radiotherapy with Immunotherapy and Anti-Angiogenic Therapy for Advanced HER2-Negative Breast Cancer: a Single-Arm Study
Clinical trial NCT06890871 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06890871
- Sponsor
- Zhongnan Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2025-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.